Q1 Earnings Estimate for Revvity Issued By Leerink Partnrs

Revvity Inc. (NYSE:RVTY - Free Report) - Equities researchers at Leerink Partnrs dropped their Q1 2026 EPS estimates for Revvity in a research note issued on Monday, June 23rd. Leerink Partnrs analyst P. Souda now forecasts that the company will earn $1.14 per share for the quarter, down from their previous estimate of $1.15. The consensus estimate for Revvity's current full-year earnings is $4.94 per share. Leerink Partnrs also issued estimates for Revvity's Q3 2026 earnings at $1.38 EPS and FY2027 earnings at $6.31 EPS.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.05. Revvity had a return on equity of 7.73% and a net margin of 10.35%. The business had revenue of $664.76 million for the quarter, compared to analysts' expectations of $662.30 million. During the same period in the prior year, the firm posted $0.98 EPS. The firm's quarterly revenue was up 2.3% on a year-over-year basis.

A number of other equities analysts have also weighed in on the company. Barclays decreased their target price on Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Robert W. Baird decreased their price objective on shares of Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a report on Tuesday, April 29th. Wall Street Zen downgraded shares of Revvity from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Wells Fargo & Company dropped their target price on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a report on Thursday, April 17th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a research note on Tuesday, April 29th. Five equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $125.64.

Revvity Trading Up 0.0%

Shares of NYSE:RVTY opened at $95.01 on Tuesday. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.58 and a quick ratio of 2.99. Revvity has a 1 year low of $87.70 and a 1 year high of $129.50. The company has a market cap of $11.20 billion, a P/E ratio of 40.43, a PEG ratio of 2.32 and a beta of 0.97. The stock's fifty day moving average price is $93.00 and its 200-day moving average price is $105.85.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date is Friday, July 18th. Revvity's payout ratio is 11.91%.

Institutional Investors Weigh In On Revvity

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Principal Securities Inc. increased its position in Revvity by 54.9% in the fourth quarter. Principal Securities Inc. now owns 598 shares of the company's stock worth $67,000 after buying an additional 212 shares in the last quarter. Sanctuary Advisors LLC bought a new position in shares of Revvity during the 4th quarter valued at approximately $209,000. Private Advisor Group LLC increased its holdings in Revvity by 5.3% in the 4th quarter. Private Advisor Group LLC now owns 4,254 shares of the company's stock worth $475,000 after acquiring an additional 213 shares in the last quarter. Ieq Capital LLC bought a new stake in Revvity during the 4th quarter worth approximately $223,000. Finally, Handelsbanken Fonder AB raised its stake in Revvity by 4.9% during the 4th quarter. Handelsbanken Fonder AB now owns 33,960 shares of the company's stock worth $3,790,000 after acquiring an additional 1,600 shares during the period. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.